CD19 and congenital rubella syndrome: In the subgroup analysis, the incidence rate of CV events (CRS grade ≥ 2) was 9.5% (95% CI: 0.048–0.163) for the CD19 subgroup and 15.4% (95% CI: 0.119–0.200) for others (Supplementary Table S3).